Early research (Phase 1)Study completedNCT03002376
What this trial is testing
An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Melanoma Patients Receiving REGN2810 (Anti-PD-1)
Who this might be right for
Melanoma
Regeneron Pharmaceuticals 47